GO:0030122 | AP-2 adaptor complex | 7.88e-05 | 7.69e-01 | 7.177 | 2 | 2 | 9 |
GO:0048268 | clathrin coat assembly | 7.88e-05 | 7.69e-01 | 7.177 | 2 | 2 | 9 |
GO:0008380 | RNA splicing | 9.28e-05 | 9.06e-01 | 3.980 | 4 | 21 | 165 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 8.14e-04 | 1.00e+00 | 5.539 | 2 | 2 | 28 |
GO:0000398 | mRNA splicing, via spliceosome | 8.92e-04 | 1.00e+00 | 3.931 | 3 | 15 | 128 |
GO:0044212 | transcription regulatory region DNA binding | 1.23e-03 | 1.00e+00 | 3.772 | 3 | 13 | 143 |
GO:0005654 | nucleoplasm | 1.26e-03 | 1.00e+00 | 2.157 | 6 | 68 | 876 |
GO:0004832 | valine-tRNA ligase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0010994 | free ubiquitin chain polymerization | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0033688 | regulation of osteoblast proliferation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0035887 | aortic smooth muscle cell differentiation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 2 |
GO:0042826 | histone deacetylase binding | 3.46e-03 | 1.00e+00 | 4.489 | 2 | 5 | 58 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0010669 | epithelial structure maintenance | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0030308 | negative regulation of cell growth | 5.01e-03 | 1.00e+00 | 4.217 | 2 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 5.58e-03 | 1.00e+00 | 4.137 | 2 | 5 | 74 |
GO:0036089 | cleavage furrow formation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0010467 | gene expression | 7.49e-03 | 1.00e+00 | 2.283 | 4 | 49 | 535 |
GO:0030274 | LIM domain binding | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0010458 | exit from mitosis | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0035519 | protein K29-linked ubiquitination | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0043931 | ossification involved in bone maturation | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0044314 | protein K27-linked ubiquitination | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0051488 | activation of anaphase-promoting complex activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 3 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0085020 | protein K6-linked ubiquitination | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0043297 | apical junction assembly | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0006895 | Golgi to endosome transport | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0035615 | clathrin adaptor activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0007617 | mating behavior | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.15e-02 | 1.00e+00 | 2.623 | 3 | 17 | 317 |
GO:0006878 | cellular copper ion homeostasis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0032456 | endocytic recycling | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0071354 | cellular response to interleukin-6 | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0030100 | regulation of endocytosis | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0072583 | clathrin-mediated endocytosis | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0016050 | vesicle organization | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0001967 | suckling behavior | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0071564 | npBAF complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 3 | 10 |
GO:0050919 | negative chemotaxis | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0042802 | identical protein binding | 1.55e-02 | 1.00e+00 | 2.464 | 3 | 15 | 354 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 4 | 11 |
GO:0071565 | nBAF complex | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 3 | 11 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.95e-02 | 1.00e+00 | 3.197 | 2 | 5 | 142 |
GO:0016514 | SWI/SNF complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0050772 | positive regulation of axonogenesis | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0005680 | anaphase-promoting complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0031593 | polyubiquitin binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 15 |
GO:0070932 | histone H3 deacetylation | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 15 |
GO:0032467 | positive regulation of cytokinesis | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 16 |
GO:0016032 | viral process | 2.57e-02 | 1.00e+00 | 2.190 | 3 | 30 | 428 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0001105 | RNA polymerase II transcription coactivator activity | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 2 | 19 |
GO:0060170 | ciliary membrane | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 19 |
GO:0000166 | nucleotide binding | 2.91e-02 | 1.00e+00 | 2.887 | 2 | 13 | 176 |
GO:0005634 | nucleus | 3.02e-02 | 1.00e+00 | 0.852 | 9 | 158 | 3246 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.03e-02 | 1.00e+00 | 2.099 | 3 | 29 | 456 |
GO:0070979 | protein K11-linked ubiquitination | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0001942 | hair follicle development | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 21 |
GO:0050690 | regulation of defense response to virus by virus | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 22 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 1 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 3 | 24 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 3.65e-02 | 1.00e+00 | 2.710 | 2 | 8 | 199 |
GO:0030901 | midbrain development | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 3 | 25 |
GO:0006281 | DNA repair | 3.78e-02 | 1.00e+00 | 2.681 | 2 | 24 | 203 |
GO:0051496 | positive regulation of stress fiber assembly | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 26 |
GO:0019899 | enzyme binding | 4.02e-02 | 1.00e+00 | 2.632 | 2 | 7 | 210 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 27 |
GO:0005524 | ATP binding | 4.17e-02 | 1.00e+00 | 1.546 | 4 | 37 | 892 |
GO:0050885 | neuromuscular process controlling balance | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 28 |
GO:0016881 | acid-amino acid ligase activity | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 3 | 28 |
GO:0043231 | intracellular membrane-bounded organelle | 4.30e-02 | 1.00e+00 | 2.578 | 2 | 8 | 218 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 4 | 29 |
GO:0008094 | DNA-dependent ATPase activity | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 5 | 29 |
GO:0032154 | cleavage furrow | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 30 |
GO:0045111 | intermediate filament cytoskeleton | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 3 | 31 |
GO:0035019 | somatic stem cell maintenance | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 32 |
GO:0005515 | protein binding | 4.97e-02 | 1.00e+00 | 0.659 | 10 | 198 | 4124 |
GO:0007411 | axon guidance | 5.00e-02 | 1.00e+00 | 2.458 | 2 | 8 | 237 |
GO:0003677 | DNA binding | 5.04e-02 | 1.00e+00 | 1.459 | 4 | 52 | 947 |
GO:0021762 | substantia nigra development | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0003712 | transcription cofactor activity | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 3 | 34 |
GO:0007254 | JNK cascade | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0008565 | protein transporter activity | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 35 |
GO:0050434 | positive regulation of viral transcription | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 35 |
GO:0030900 | forebrain development | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 36 |
GO:0003723 | RNA binding | 5.39e-02 | 1.00e+00 | 2.398 | 2 | 22 | 247 |
GO:0030334 | regulation of cell migration | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 36 |
GO:0030666 | endocytic vesicle membrane | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 36 |
GO:0005905 | coated pit | 5.54e-02 | 1.00e+00 | 4.137 | 1 | 2 | 37 |
GO:0048511 | rhythmic process | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 6 | 40 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 1 | 42 |
GO:0004386 | helicase activity | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 3 | 42 |
GO:0001047 | core promoter binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 4 | 42 |
GO:0008285 | negative regulation of cell proliferation | 6.60e-02 | 1.00e+00 | 2.233 | 2 | 11 | 277 |
GO:0008203 | cholesterol metabolic process | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 48 |
GO:0006310 | DNA recombination | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 3 | 53 |
GO:0042393 | histone binding | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 3 | 54 |
GO:0006338 | chromatin remodeling | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 7 | 55 |
GO:0031901 | early endosome membrane | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 1 | 58 |
GO:0000785 | chromatin | 8.70e-02 | 1.00e+00 | 3.464 | 1 | 6 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 4 | 61 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 9.54e-02 | 1.00e+00 | 3.324 | 1 | 7 | 65 |
GO:0006897 | endocytosis | 9.82e-02 | 1.00e+00 | 3.280 | 1 | 2 | 67 |
GO:0010951 | negative regulation of endopeptidase activity | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 2 | 71 |
GO:0016020 | membrane | 1.04e-01 | 1.00e+00 | 1.109 | 4 | 56 | 1207 |
GO:0030496 | midbody | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 6 | 73 |
GO:0016363 | nuclear matrix | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 10 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 2 | 76 |
GO:0017124 | SH3 domain binding | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 2 | 76 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.12e-01 | 1.00e+00 | 1.788 | 2 | 21 | 377 |
GO:0005938 | cell cortex | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 5 | 82 |
GO:0044822 | poly(A) RNA binding | 1.19e-01 | 1.00e+00 | 1.289 | 3 | 45 | 799 |
GO:0005215 | transporter activity | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 2 | 83 |
GO:0005829 | cytosol | 1.23e-01 | 1.00e+00 | 0.865 | 5 | 88 | 1787 |
GO:0030027 | lamellipodium | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 88 |
GO:0006886 | intracellular protein transport | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.30e-01 | 1.00e+00 | 2.855 | 1 | 4 | 90 |
GO:0008201 | heparin binding | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 4 | 91 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.52e-01 | 1.00e+00 | 2.605 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.54e-01 | 1.00e+00 | 2.592 | 1 | 2 | 108 |
GO:0000790 | nuclear chromatin | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 9 | 109 |
GO:0006397 | mRNA processing | 1.56e-01 | 1.00e+00 | 2.565 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 7 | 119 |
GO:0006184 | GTP catabolic process | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 7 | 130 |
GO:0005737 | cytoplasm | 1.95e-01 | 1.00e+00 | 0.569 | 6 | 127 | 2633 |
GO:0030168 | platelet activation | 1.96e-01 | 1.00e+00 | 2.207 | 1 | 5 | 141 |
GO:0005667 | transcription factor complex | 2.04e-01 | 1.00e+00 | 2.147 | 1 | 8 | 147 |
GO:0007399 | nervous system development | 2.10e-01 | 1.00e+00 | 2.099 | 1 | 4 | 152 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.21e-01 | 1.00e+00 | 2.016 | 1 | 18 | 161 |
GO:0007264 | small GTPase mediated signal transduction | 2.37e-01 | 1.00e+00 | 1.904 | 1 | 8 | 174 |
GO:0004842 | ubiquitin-protein transferase activity | 2.42e-01 | 1.00e+00 | 1.863 | 1 | 17 | 179 |
GO:0003713 | transcription coactivator activity | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 21 | 184 |
GO:0005856 | cytoskeleton | 2.55e-01 | 1.00e+00 | 1.777 | 1 | 8 | 190 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.60e-01 | 1.00e+00 | 1.016 | 2 | 29 | 644 |
GO:0005743 | mitochondrial inner membrane | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 12 | 197 |
GO:0005739 | mitochondrion | 2.69e-01 | 1.00e+00 | 0.982 | 2 | 32 | 659 |
GO:0015031 | protein transport | 2.70e-01 | 1.00e+00 | 1.681 | 1 | 10 | 203 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.70e-01 | 1.00e+00 | 1.681 | 1 | 14 | 203 |
GO:0007268 | synaptic transmission | 2.83e-01 | 1.00e+00 | 1.605 | 1 | 7 | 214 |
GO:0030054 | cell junction | 2.87e-01 | 1.00e+00 | 1.578 | 1 | 5 | 218 |
GO:0005886 | plasma membrane | 2.88e-01 | 1.00e+00 | 0.546 | 4 | 46 | 1784 |
GO:0006200 | ATP catabolic process | 2.89e-01 | 1.00e+00 | 1.572 | 1 | 13 | 219 |
GO:0030198 | extracellular matrix organization | 2.91e-01 | 1.00e+00 | 1.559 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.00e-01 | 1.00e+00 | 1.507 | 1 | 4 | 229 |
GO:0006355 | regulation of transcription, DNA-templated | 3.02e-01 | 1.00e+00 | 0.865 | 2 | 31 | 715 |
GO:0008283 | cell proliferation | 3.11e-01 | 1.00e+00 | 1.446 | 1 | 8 | 239 |
GO:0005925 | focal adhesion | 3.56e-01 | 1.00e+00 | 1.207 | 1 | 14 | 282 |
GO:0009986 | cell surface | 3.65e-01 | 1.00e+00 | 1.162 | 1 | 5 | 291 |
GO:0007596 | blood coagulation | 4.12e-01 | 1.00e+00 | 0.941 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.13e-01 | 1.00e+00 | 0.933 | 1 | 23 | 341 |
GO:0005509 | calcium ion binding | 4.23e-01 | 1.00e+00 | 0.891 | 1 | 9 | 351 |
GO:0070062 | extracellular vesicular exosome | 4.74e-01 | 1.00e+00 | 0.251 | 3 | 51 | 1641 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.275 | 2 | 47 | 1076 |
GO:0045087 | innate immune response | 5.09e-01 | 1.00e+00 | 0.526 | 1 | 12 | 452 |
GO:0005730 | nucleolus | 5.74e-01 | 1.00e+00 | 0.097 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.98e-01 | 1.00e+00 | 0.179 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 6.25e-01 | 1.00e+00 | 0.075 | 1 | 24 | 618 |
GO:0008270 | zinc ion binding | 6.87e-01 | 1.00e+00 | -0.159 | 1 | 39 | 727 |
GO:0016021 | integral component of membrane | 9.22e-01 | 1.00e+00 | -1.229 | 1 | 19 | 1526 |